BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kelly D, Verkade HJ, Rajanayagam J, Mckiernan P, Mazariegos G, Hübscher S. Late graft hepatitis and fibrosis in pediatric liver allograft recipients: Current concepts and future developments. Liver Transpl 2016;22:1593-602. [DOI: 10.1002/lt.24616] [Cited by in Crossref: 69] [Cited by in F6Publishing: 46] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 McLin VA, Allen U, Boyer O, Bucuvalas J, Colledan M, Cuturi MC, d'Antiga L, Debray D, Dezsofi A, Goyet JV, Dhawan A, Durmaz O, Falk C, Feng S, Fischler B, Franchi-Abella S, Frauca E, Ganschow R, Gottschalk S, Hadzic N, Hierro L, Horslen S, Hubscher S, Karam V, Kelly D, Maecker-Kolhoff B, Mazariegos G, McKiernan P, Melk A, Nobili V, Ozgenç F, Reding R, Sciveres M, Sharif K, Socha P, Toso C, Vajro P, Verma A, Wildhaber BE, Baumann U. Early and Late Factors Impacting Patient and Graft Outcome in Pediatric Liver Transplantation: Summary of an ESPGHAN Monothematic Conference. J Pediatr Gastroenterol Nutr 2017;65:e53-9. [PMID: 28319600 DOI: 10.1097/MPG.0000000000001564] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
2 Stormon MO, Hardikar W, Evans HM, Hodgkinson P. Paediatric liver transplantation in Australia and New Zealand: 1985-2018. J Paediatr Child Health 2020;56:1739-46. [PMID: 32649047 DOI: 10.1111/jpc.14969] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Qin T, Fu J, Verkade HJ. The role of the gut microbiome in graft fibrosis after pediatric liver transplantation. Hum Genet 2021;140:709-24. [PMID: 32920649 DOI: 10.1007/s00439-020-02221-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Vinciguerra T, Brunati A, David E, Longo F, Pinon M, Ricceri F, Castellino L, Piga A, Giraudo MT, Tandoi F. Transient elastography for non-invasive evaluation of post-transplant liver graft fibrosis in children. Pediatr Transplant. 2018;22. [PMID: 29369488 DOI: 10.1111/petr.13125] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
5 Cernigliaro V, Peluso R, Zedda B, Silengo L, Tolosano E, Pellicano R, Altruda F, Fagoonee S. Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases. Cells 2020;9:E386. [PMID: 32046114 DOI: 10.3390/cells9020386] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Kubal CA, Mangus R, Ekser B, Mihaylov P, Ceballos B, Higgins N, Chalasani N, Ghabril M, Nephew L, Lobashevsky A. Class II Human Leukocyte Antigen Epitope Mismatch Predicts De Novo Donor-Specific Antibody Formation After Liver Transplantation. Liver Transpl 2018;24:1101-8. [PMID: 30142248 DOI: 10.1002/lt.25286] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
7 Feng S, Bucuvalas J. Reply. Liver Transpl 2018;24:1305-6. [PMID: 30120815 DOI: 10.1002/lt.25288] [Reference Citation Analysis]
8 Kelly D, Hartleif S, Verkade HJ, Rajanayagam J, McKiernan P, Mazariegos G, Hübscher S. Reply. Liver Transpl 2017;23:405-6. [PMID: 28027613 DOI: 10.1002/lt.24705] [Reference Citation Analysis]
9 Bosma PJ, Wits M, Oude-Elferink RP. Gene Therapy for Progressive Familial Intrahepatic Cholestasis: Current Progress and Future Prospects. Int J Mol Sci 2020;22:E273. [PMID: 33383947 DOI: 10.3390/ijms22010273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Demetris AJ. Longterm outcome of the liver graft: The pathologist's perspective. Liver Transpl 2017;23:S70-5. [DOI: 10.1002/lt.24851] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
11 Winters AC, Mittal R, Schiano TD. A review of the use of transient elastography in the assessment of fibrosis and steatosis in the post-liver transplant patient. Clin Transplant. 2019;33:e13700. [PMID: 31441967 DOI: 10.1111/ctr.13700] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
12 Vionnet J, Sempoux C, Pascual M, Sánchez-fueyo A, Colmenero J. Donor-specific antibodies in liver transplantation. Gastroenterología y Hepatología 2020;43:34-45. [DOI: 10.1016/j.gastrohep.2019.09.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
13 Gu C, Shi X, Dang X, Chen J, Chen C, Chen Y, Pan X, Huang T. Identification of Common Genes and Pathways in Eight Fibrosis Diseases. Front Genet 2020;11:627396. [PMID: 33519923 DOI: 10.3389/fgene.2020.627396] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
14 Rawal N, Yazigi N. Pediatric Liver Transplantation. Pediatr Clin North Am. 2017;64:677-684. [PMID: 28502445 DOI: 10.1016/j.pcl.2017.02.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
15 Berumen J, Baglieri J, Kisseleva T, Mekeel K. Liver fibrosis: Pathophysiology and clinical implications. Wiley Interdiscip Rev Syst Biol Med. 2020;e1499. [PMID: 32713091 DOI: 10.1002/wsbm.1499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Qiu C, Sha T, Yin T, Zhang W, Chen X, Miao X, Zheng R, Shuai X, Ren J. VEGFR2-targeted ultrasound molecular imaging of angiogenesis to evaluate liver allograft fibrosis. Biomater Sci 2021;9:5802-11. [PMID: 34008615 DOI: 10.1039/d1bm00100k] [Reference Citation Analysis]
17 Voutilainen SH, Kosola SK, Lohi J, Jahnukainen T, Pakarinen MP, Jalanko H. Expression of fibrosis-related genes in liver allografts: Association with histology and long-term outcome after pediatric liver transplantation. Clin Transplant 2021;:e14373. [PMID: 34043847 DOI: 10.1111/ctr.14373] [Reference Citation Analysis]
18 Feng S, Bucuvalas JC, Demetris AJ, Burrell BE, Spain KM, Kanaparthi S, Magee JC, Ikle D, Lesniak A, Lozano JJ, Alonso EM, Bray RA, Bridges NE, Doo E, Gebel HM, Gupta NA, Himes RW, Jackson AM, Lobritto SJ, Mazariegos GV, Ng VL, Rand EB, Sherker AH, Sundaram S, Turmelle YP, Sanchez-Fueyo A. Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants. Gastroenterology 2018;155:1838-1851.e7. [PMID: 30144432 DOI: 10.1053/j.gastro.2018.08.023] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 14.3] [Reference Citation Analysis]
19 Chanpong A, Angkathunyakul N, Sornmayura P, Tanpowpong P, Lertudomphonwanit C, Panpikoon T, Treepongkaruna S. Late allograft fibrosis in pediatric liver transplant recipients: Assessed by histology and transient elastography. Pediatr Transplant 2019;23:e13541. [PMID: 31278842 DOI: 10.1111/petr.13541] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Cousin VL, Rougemont AL, Rubbia-Brandt L, Wildhaber BE, Villard J, Ferrari-Lacraz S, McLin VA. Peripheral Donor-specific Antibodies Are Associated With Histology and Cellular Subtypes in Protocol Liver Biopsies of Pediatric Recipients. Transplantation 2020;104:1633-43. [PMID: 32732841 DOI: 10.1097/TP.0000000000003099] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
21 Vannas M, Arola J, Nordin A, Isoniemi H. Value of posttransplant protocol biopsies in 2 biliary autoimmune liver diseases: A step toward personalized immunosuppressive treatment. Medicine (Baltimore) 2022;101:e28509. [PMID: 35029206 DOI: 10.1097/MD.0000000000028509] [Reference Citation Analysis]
22 Dubois M, Ronot M, Houssel-Debry P, Brun V, Rayar M, Auger M, Beuzit L, Turlin B, Aubé C, Paisant A. Performance of B-mode ratio and 2D shear wave elastography for the detection and quantification of hepatic steatosis and fibrosis after liver transplantation. Eur J Gastroenterol Hepatol 2020;32:222-30. [PMID: 31464783 DOI: 10.1097/MEG.0000000000001500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
23 Londoño MC, Souza LN, Lozano JJ, Miquel R, Abraldes JG, Llovet LP, Quaglia A, Rimola A, Navasa M, Sánchez-Fueyo A. Molecular profiling of subclinical inflammatory lesions in long-term surviving adult liver transplant recipients. J Hepatol 2018;69:626-34. [PMID: 29709679 DOI: 10.1016/j.jhep.2018.04.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
24 Ruth N, Sharif K, Legarda M, Smith M, Lewis P, Lloyd C, Mirza D, Kelly D. What is the long-term outlook for young people following liver transplant? A single-centre retrospective analysis of physical and psychosocial outcomes. Pediatr Transplant 2020;24:e13782. [PMID: 32678500 DOI: 10.1111/petr.13782] [Reference Citation Analysis]
25 Mcdiarmid SV. Vascularized composite allotransplantation in children: what we can learn from solid organ transplantation. Current Opinion in Organ Transplantation 2018;23:605-14. [DOI: 10.1097/mot.0000000000000576] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Markiewicz-Kijewska M, Szymańska S, Pyzlak M, Kaliciński P, Teisseyre J, Kowalski A, Jankowska I, Czubkowski P, Ismail H. Liver Histopathology in Late Protocol Biopsies after Pediatric Liver Transplantation. Children (Basel) 2021;8:671. [PMID: 34438562 DOI: 10.3390/children8080671] [Reference Citation Analysis]
27 Angelico R, Spada M, Liccardo D, Pedini D, Grimaldi C, Pietrobattista A, Basso MS, Della Corte C, Mosca A, Saffioti MC, Alaggio R, Maggiore G, Candusso M, Francalanci P. Allograft Fibrosis After Pediatric Liver Transplantation: Incidence, Risk Factors, and Evolution. Liver Transpl 2021. [PMID: 34164907 DOI: 10.1002/lt.26218] [Reference Citation Analysis]
28 Di Dato F, Nunziata F, Rosa M, Iorio R, Spagnuolo MI. Tubercular hemoptysis in a young liver transplanted patient: Case report. Medicine (Baltimore) 2019;98:e16761. [PMID: 31415374 DOI: 10.1097/MD.0000000000016761] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Legaz I, Boix F, López M, Alfaro R, Galián JA, Llorente S, Campillo JA, Botella C, Ramírez P, Sánchez-Bueno F, Pons JA, Moya-Quiles MR, Minguela A, Muro M. Influence of Preformed Antibodies in Liver Transplantation. J Clin Med 2020;9:E708. [PMID: 32151032 DOI: 10.3390/jcm9030708] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
30 Sheikh A, Chau KY, Evans HM. Histological findings in protocol biopsies following pediatric liver transplant: Low incidence of abnormalities at 5 years. Pediatr Transplant. 2018;22:e13212. [PMID: 29749699 DOI: 10.1111/petr.13212] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
31 Wesson RN, Etchill EW, Garonzik-Wang J. Application and interpretation of histocompatibility data in liver transplantation. Curr Opin Organ Transplant. 2017;22:499-504. [PMID: 28708813 DOI: 10.1097/mot.0000000000000450] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
32 Celaj S, Levitsky J. Profiling the liver graft. Curr Opin Organ Transplant 2021;26:17-22. [PMID: 33278149 DOI: 10.1097/MOT.0000000000000834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Wu Y, Huang M, Sun H, Zhou X, Zhou R, Gu G, Xia Q. Role of Innate Immunity in Pediatric Post-transplant Idiopathic Liver Fibrosis. Front Immunol 2020;11:2111. [PMID: 33193293 DOI: 10.3389/fimmu.2020.02111] [Reference Citation Analysis]
34 Lee CK, Nastasio S, Mitchell PD, Fawaz R, Elisofon SA, Vakili K, Kim HB, Nguyen D, Jonas MM. Transient elastography assessment of liver allograft fibrosis in pediatric transplant recipients. Pediatr Transplant 2020;24:e13736. [PMID: 32432836 DOI: 10.1111/petr.13736] [Reference Citation Analysis]
35 Hirao H, Ito T, Kadono K, Kojima H, Naini BV, Nakamura K, Kageyama S, Busuttil RW, Kupiec-Weglinski JW, Kaldas FM. Donor Hepatic Occult Collagen Deposition Predisposes to Peritransplant Stress and Impacts Human Liver Transplantation. Hepatology 2021;74:2759-73. [PMID: 34170562 DOI: 10.1002/hep.32030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
36 Saelens EM, Van Biervliet S, Vande Velde S, Van Winckel M, Rogiers X, Vanlander A, Daniëls L, Bonroy C, De Bruyne RML. Autoantibodies and Donor-specific Antibodies are Associated With Graft Dysfunction in Pediatric Liver Transplantation. J Pediatr Gastroenterol Nutr 2021;72:661-6. [PMID: 32810036 DOI: 10.1097/MPG.0000000000002913] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Vo HD, Radio SJ, Granader EJ, Wojkiewicz LE, Turner P, Mauch TJ. Diagnostic performance of 2D-shear wave elastography and serum fibrosis markers for evaluation of hepatic graft fibrosis in pediatric liver-inclusive transplant recipients: A prospective pilot study. Pediatr Transplant 2022;:e14225. [PMID: 35005824 DOI: 10.1111/petr.14225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Brown RM, Hübscher SG. Role of Histology Following Pediatric Liver Transplantation. Pediatric Liver Transplantation. Elsevier; 2021. pp. 223-32. [DOI: 10.1016/b978-0-323-63671-1.00024-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Koo J, Wang HL. Acute, Chronic, and Humoral Rejection. Surgical Pathology Clinics 2018;11:431-52. [DOI: 10.1016/j.path.2018.02.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
40 Martinelli J, Habes D, Majed L, Guettier C, Gonzalès E, Linglart A, Larue C, Furlan V, Pariente D, Baujard C, Branchereau S, Gauthier F, Jacquemin E, Bernard O. Long-term outcome of liver transplantation in childhood: A study of 20-year survivors. Am J Transplant 2018;18:1680-9. [PMID: 29247469 DOI: 10.1111/ajt.14626] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 10.5] [Reference Citation Analysis]
41 Gu L, Lv Z, Wu H, Hou Y, Gao R, Xi Z, Fang H, Feng H, Jiang L, Xia Q. Two-Dimensional Shear Wave Elastography Evaluation of Post-transplantation Complications in Pediatric Receipt: A Retrospective Cohort. Front Pediatr 2022;10:918145. [DOI: 10.3389/fped.2022.918145] [Reference Citation Analysis]
42 Iacob S, Cicinnati V, Kabar I, Hüsing-Kabar A, Radtke A, Iacob R, Baba H, Schmidt HH, Paul A, Beckebaum S. Prediction of late allograft dysfunction following liver transplantation by immunological blood biomarkers. Transpl Immunol 2021;69:101448. [PMID: 34391882 DOI: 10.1016/j.trim.2021.101448] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Vionnet J, Miquel R, Abraldes JG, Wall J, Kodela E, Lozano JJ, Ruiz P, Navasa M, Marshall A, Nevens F, Gelson W, Leithead J, Masson S, Jaeckel E, Taubert R, Tachtatzis P, Eurich D, Simpson KJ, Bonaccorsi-Riani E, Feng S, Bucuvalas J, Ferguson J, Quaglia A, Sidorova J, Elstad M, Douiri A, Sánchez-Fueyo A. Non-invasive alloimmune risk stratification of long-term liver transplant recipients. J Hepatol 2021:S0168-8278(21)02001-8. [PMID: 34437910 DOI: 10.1016/j.jhep.2021.08.007] [Reference Citation Analysis]
44 Vo HD, Radio SJ, Reyes-Santiago EM, Mauch TJ. Post-transplant hepatic fibrosis in pediatric liver-small bowel transplant recipients: A single-center, retrospective, observational study. Pediatr Transplant 2021;25:e13965. [PMID: 33378567 DOI: 10.1111/petr.13965] [Reference Citation Analysis]
45 Perito ER, Martinez M, Turmelle YP, Mason K, Spain KM, Bucuvalas JC, Feng S. Posttransplant biopsy risk for stable long-term pediatric liver transplant recipients: 451 percutaneous biopsies from two multicenter immunosuppression withdrawal trials. Am J Transplant 2019;19:1545-51. [PMID: 30614623 DOI: 10.1111/ajt.15255] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
46 Veraldi S, Pietrobattista A, Liccardo D, Basso MS, Mosca A, Alterio T, Cardile S, Benedetti S, Della Corte C, Candusso M. Fat soluble vitamins deficiency in pediatric chronic liver disease: The impact of liver transplantation. Digestive and Liver Disease 2020;52:308-13. [DOI: 10.1016/j.dld.2019.10.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Ewing CB, Soltys KA, Strauss KA, Sindhi R, Vockley J, McKiernan P, Squires RH, Bond G, Ganoza A, Khanna A, Mazariegos GV, Squires JE. Metabolic Control and "Ideal" Outcomes in Liver Transplantation for Maple Syrup Urine Disease. J Pediatr 2021:S0022-3476(21)00558-8. [PMID: 34153280 DOI: 10.1016/j.jpeds.2021.06.028] [Reference Citation Analysis]
48 Varma S, Sokal EM. Late graft hepatitis and fibrosis in pediatric liver allograft recipients: Current concepts and future developments. Liver Transpl 2017;23:403-4. [PMID: 28027624 DOI: 10.1002/lt.24707] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Voutilainen SH, Kosola SK, Lohi J, Mutka A, Jahnukainen T, Pakarinen M, Jalanko H. Expression of 6 Biomarkers in Liver Grafts After Pediatric Liver Transplantation: Correlations with Histology, Biochemistry, and Outcome. Ann Transplant 2020;25:e925980. [PMID: 33060556 DOI: 10.12659/AOT.925980] [Reference Citation Analysis]
50 De Martin E, Hessheimer A, Chadha R, Kabacam G, Rajanayagam J, Kirchner V, Kalisvaart M, Scalera I, Bhat M, Contreras A, Bhangui P. Report of the 24th Annual Congress of the International Liver Transplantation Society. Transplantation 2019;103:465-9. [DOI: 10.1097/tp.0000000000002549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
51 Barbetta A, Butler C, Barhouma S, Hogen R, Rocque B, Goldbeck C, Schilperoort H, Meeberg G, Shapiro J, Kwon YK, Kohli R, Emamaullee J. Living Donor Versus Deceased Donor Pediatric Liver Transplantation: A Systematic Review and Meta-analysis. Transplant Direct 2021;7:e767. [PMID: 34557584 DOI: 10.1097/TXD.0000000000001219] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Vo HD, Harp KA, Mauch TJ. Diagnostic performance of non-invasive tests for evaluation of hepatic graft fibrosis in pediatric liver transplantation: A scoping review. Transplant Rev (Orlando) 2020;34:100568. [PMID: 32713759 DOI: 10.1016/j.trre.2020.100568] [Reference Citation Analysis]
53 Issa F, Strober S, Leventhal JR, Kawai T, Kaufman DB, Levitsky J, Sykes M, Mas V, Wood KJ, Bridges N, Welniak LA, Chandran S, Madsen JC, Nickerson P, Demetris AJ, Lakkis FG, Thomson AW. The Fourth International Workshop on Clinical Transplant Tolerance. Am J Transplant 2021;21:21-31. [PMID: 32529725 DOI: 10.1111/ajt.16139] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
54 Hogen R, DiNorcia J, Dhanireddy K. Antibody-mediated rejection: what is the clinical relevance? Curr Opin Organ Transplant 2017;22:97-104. [PMID: 28060025 DOI: 10.1097/MOT.0000000000000391] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
55 Gambella A, Mastracci L, Caporalini C, Francalanci P, Mescoli C, Ferro J, Alaggio R, Grillo F. Not only a small liver - The pathologist's perspective in the pediatric liver transplant setting. Pathologica 2022;114:89-103. [PMID: 35212319 DOI: 10.32074/1591-951X-753] [Reference Citation Analysis]